The U.S. Food and Drug Administration (FDA) has approved the first oral treatment for eosinophilic esophagitis, a rare condition caused by allergic inflammation in the esophagus that can make it hard ...
Please provide your email address to receive an email when new articles are posted on . Risk and annualized rate of severe exacerbations dropped with as-needed use of albuterol-budesonide vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results